<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001638'>Cardiomyopathy</z:hpo> is a significant component in Duchenne <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although mdx mice are deficient in dystrophin, they only develop mild indicators of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> before 1year-of-age, making therapeutic investigations using this model lengthy </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, mdx mice also lacking utrophin (utrn(-/-);mdx) show severely reduced cardiac contractile function and histological indicators of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> by 8-10weeks-of-age </plain></SENT>
<SENT sid="3" pm="."><plain>Here we demonstrate that utrn(-/-);mdx mice show a similar pattern of cardiac damage to that in dystrophic patients </plain></SENT>
<SENT sid="4" pm="."><plain>Matrix metalloproteinases required for ventricular remodeling during the evolution of <z:hpo ids='HP_0001635'>heart failure</z:hpo> are upregulated in utrn(-/-);mdx mice concurrent with the <z:hpo ids='HP_0003674'>onset</z:hpo> of cardiac pathology by 10weeks-of-age </plain></SENT>
<SENT sid="5" pm="."><plain>Matrix metalloproteinase activity is further dysregulated due to reduced levels of endogenous tissue inhibitors and co-localizes with fibroblasts and collagen I-containing scars </plain></SENT>
<SENT sid="6" pm="."><plain>utrn(-/-);mdx mice are therefore a very useful model for investigating potential cardiac therapies </plain></SENT>
</text></document>